Flupentixol DecanoateThird Party Manufacturing in India

Flupentixol Decanoate works by blocking postsynaptic dopamine D1 and D2 receptors in the brain's mesolimbic pathway. It inhibits dopamine transmission to help the body suppress psychotic thoughts, hallucinations, and delusions. Unlike rapid-acting oral neuroleptics, it is esterified in an oil medium to ensure slow, sustained release over several weeks from the muscle depot. It is highly effective and well-tolerated for maintaining patient compliance.

Therapeutic Uses

• Chronic Schizophrenia: Serves as maintenance therapy to prevent relapse in patients with unstable oral compliance.
• Paranoid Psychoses: Suppresses persistent delusions and long-term cognitive distortions in chronic psychiatric cases.

Why Manufacturers Choose Flupentixol Decanoate

Flupentixol Decanoate third party manufacturing in India is a critical sub-segment in neuropsychiatry portfolios due to the global emphasis on long-acting injectable antipsychotics. Depot injections maintain high customer retention because patients remain on the same therapy for months. Our partner production hubs excel in handling highly sensitive, viscous oil-based crystal-free formulations. Processing through WHO-GMP certified partner sites ensures uniform release dynamics and low side-effect profiles.